Senzime Secures FDA Clearance for Enhanced TetraGraph
UPPSALA, Sweden, May 27, 2026 Senzime AB announced that the U.S. Food and Drug Administration has granted an additional...
Alzheimer’s Disease ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
UPPSALA, Sweden, May 27, 2026 Senzime AB announced that the U.S. Food and Drug Administration has granted an additional...
GALWAY, Ireland, May 20, 2026 Medtronic plc has announced its intent to acquire SPR Therapeutics, Inc. in a deal...
VANCOUVER, British Columbia, May 14, 2026 Zymeworks Inc. announced that its Board of Directors has approved a new 2026...
VALENCIA, Calif., May 14, 2026 SetPoint Medical announced the publication of a peer-reviewed health economics study demonstrating that its...
PALO ALTO, Calif., May 14, 2026 Glooko, Inc. announced that the U.S. Food and Drug Administration has granted 510(k)...
WALTHAM, Mass., May 13, 2026 Revvity, Inc. has received U.S. FDA clearance for its Total Testosterone automated chemiluminescence immunoassay...
